Abstracts
Showing 795 abstracts.
Characteristics and Management of Highly Active Antiretroviral Treatment Failure among Children and Adolescents Perinatally Infected with HIV in the US.
Conference
20th Conference on Retroviruses and Opportunistic Infections
Pharmacokinetics of Darunavir (DRV) 800 mg with Ritonavir 100 mg Once Daily in HIV-Infected Adolescents and Young Adults
Conference
20th Conference on Retroviruses and Opportunistic Infections
Study
P1058A
Mother to Child HIV Transmission is associated with a Gag-Protease-driven Viral Fitness Bottleneck
Conference
20th Conference on Retroviruses and Opportunistic Infections
Raltegravir Pharmacokinetics and Safety in Neonates (IMPAACT P1097)
Conference
20th Conference on Retroviruses and Opportunistic Infections
Study
P1097
Daily Infant Nevirapine (NVP) through Six-months of Life for Prevention of Mother-to-Child Transmission of HIV-1 (PMTCT) - Adherence and NVP Exposure (HPTN 046 Trial)
Conference
20th Conference on Retroviruses and Opportunistic Infections
Methylphenidate Concentrations and Dose Requirements in HIV-infected and Uninfected Children, Adolescents and Young Adults
Conference
20th Conference on Retroviruses and Opportunistic Infections
Study
P1080
Subtype C HIV-1 Variants Transmitted by Breastfeeding Have Less Glycosylated V2 Loops and Are More Susceptible to V2-Targeted Antibodies PG9 and PG16
Conference
20th Conference on Retroviruses and Opportunistic Infections
A Comparison of the Pharmacokinetics of Maraviroc during Pregnancy and Postpartum
Conference
20th Conference on Retroviruses and Opportunistic Infections
Study
P1026S
Genetically Determined Continental Ancestry is Independently Associated with CD4+ Count and Plasma HIV RNA Beyond Self-Reported Race and Ethnicity
Conference
20th Conference on Retroviruses and Opportunistic Infections
Pubertal Onset in HIV-infected Children in the Era of Combination Antiretroviral Treatment
Conference
20th Conference on Retroviruses and Opportunistic Infections